𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic covariation of neuroticism with monoamine oxidase activity and smoking

✍ Scribed by Kirk, Katherine M. ;Whitfield, John B. ;Pang, Dona ;Heath, Andrew C. ;Martin, Nicholas G.


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
119 KB
Volume
105
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Variation in the personality trait of neuroticism is known to be affected by genetic influences, but despite a number of association studies, the genes involved have not yet been characterized. In a recent study of platelet monoamine oxidase in 1,551 twin subjects, we found a significant association between monoamine oxidase activity and scores on the Eysenck Personality Questionnaire neuroticism scale. Further analyses presented here indicate that both neuroticism and monoamine oxidase activity are associated with variation in smoking habits, and that adjusting for the effect of smoking strengthens the association between MAO and neuroticism. Analysis of the genetic and environmental sources of covariation between neuroticism, smoking, and monoamine oxidase activity show that approximately 8% of the genetic variance in neuroticism is due to the same additive genetic effects that contribute to variation in monoamine oxidase activity, suggesting that variation in neuroticism is associated in part with aspects of serotonin metabolism. Β© 2001 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Association of monoamine oxidase (MAO) a
✍ Devor, Eric J. ;Cloninger, C. Robert ;Hoffman, Paula L. ;Tabakoff, Boris πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 576 KB

A familial/genetic study of platelet monoamine oxidase (MAO) activity in alcoholics was carried out. M A 0 activities were determined using phenylethylamine (PEA) as substrate at K, concentration (1.2 pM) and at saturating concentration (12.0 pM). Complex segregation analysis of familial data indica

A dose-ranging study of selegiline in pa
✍ Nathalie Andreu; Christine Damase-Michel; Jean-Michel Senard; Olivier Rascol; Pr πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 1 views

## Abstract A dose‐ranging study of selegiline was performed in patients with Parkinson's disease to determine the minimal dosage of the drug able to inhibit β‰₯95% of platelet monoamine oxidase (MAO) activity. Different doses of selegiline (5 or 10 mg daily, 10 or 20 mg weekly) were studied in four